Surveillance of the activity of solithromycin (CEM-101) against bacteria from respiratory tract infections

Highlights • The activity of the antibiotic solithromycin was investigated against bacteria from respiratory tract infections (RTI). • Solithromycin exhibited excellent activity against major causative RTI pathogens. • Further monitoring of the activity of solithromycin against RTI pathogens is meri...

Full description

Saved in:
Bibliographic Details
Published in:International journal of antimicrobial agents 2017-07, Vol.50 (1), p.17-22
Main Authors: Hawser, Stephen, Morrissey, Ian, Lemos, Barbara, Keedy, Kara, Fernandes, Prabhavathi
Format: Article
Language:English
Subjects:
Anti-Bacterial Agents - pharmacology
Antibiotic susceptibility
Bacteria - drug effects
Bacteria - isolation & purification
Bacterial Infections - microbiology
Community-acquired respiratory tract infection
Fourth-generation macrolide
Global Health
Humans
Infectious Disease
Macrolides - pharmacology
Microbial Sensitivity Tests
Respiratory Tract Infections - microbiology
Solithromycin
Triazoles - pharmacology
Citations: Items that this one cites
Items that cite this one
Online Access:Get full text
Tags: Add Tag
No Tags, Be the first to tag this record!
cited_by cdi_FETCH-LOGICAL-c498t-4dee2c6a0b98fbc07943b6613d1e88906231bb607521a8dd06c80dc0b312967e3
cites cdi_FETCH-LOGICAL-c498t-4dee2c6a0b98fbc07943b6613d1e88906231bb607521a8dd06c80dc0b312967e3
container_end_page 22
container_issue 1
container_start_page 17
container_title International journal of antimicrobial agents
container_volume 50
creator Hawser, Stephen
Morrissey, Ian
Lemos, Barbara
Keedy, Kara
Fernandes, Prabhavathi
description Highlights • The activity of the antibiotic solithromycin was investigated against bacteria from respiratory tract infections (RTI). • Solithromycin exhibited excellent activity against major causative RTI pathogens. • Further monitoring of the activity of solithromycin against RTI pathogens is merited.
doi_str_mv 10.1016/j.ijantimicag.2017.01.035
format article
fullrecord <record><control><sourceid>proquest_cross</sourceid><recordid>TN_cdi_proquest_miscellaneous_1896894391</recordid><sourceformat>XML</sourceformat><sourcesystem>PC</sourcesystem><els_id>S0924857917301425</els_id><sourcerecordid>1896894391</sourcerecordid><originalsourceid>FETCH-LOGICAL-c498t-4dee2c6a0b98fbc07943b6613d1e88906231bb607521a8dd06c80dc0b312967e3</originalsourceid><addsrcrecordid>eNqNkU1v1DAQhi0EotuFv4DMrT0k-COJ7QsSWhWKVMShcLYcZ9I6JPFiOyvl3-NoC0KcOFmWn3ln5jFCbykpKaHNu6F0g5mTm5w1DyUjVJSEloTXz9COSsEKoSh_jnZEsaqQtVAX6DLGgRBa86p-iS6YrCQXVOzQcL-EE7hxNLMF7HucHgEbm9zJpXW7Rz-69Bj8tFo346vDzZciz3CNzYNxc0y4zTAEZ3CfGRwgHl0wyYcVp5CfsJt7yHF-jq_Qi96MEV4_nXv0_ePNt8Ntcff10-fDh7vCVkqmouoAmG0MaZXsW0uEqnjbNJR3FKRUpGGctm1DRM2okV1HGitJZ0nLKVONAL5HV-fcY_A_F4hJTy5a2FYEv0RNpWpkDs2O9kidURt8jAF6fQxuMmHVlOhNtR70X6r1ploTqrPqXPvmqc3STtD9qfztNgOHMwB52ZODoKN1kDV3LmQluvPuv9q8_yfFjm7O2PgDVoiDX8KcbWqqI9NE329_vn15HoDQitX8F-l_qw0</addsrcrecordid><sourcetype>Aggregation Database</sourcetype><iscdi>true</iscdi><recordtype>article</recordtype><pqid>1896894391</pqid></control><display><type>article</type><title>Surveillance of the activity of solithromycin (CEM-101) against bacteria from respiratory tract infections</title><source>ScienceDirect Freedom Collection</source><creator>Hawser, Stephen ; Morrissey, Ian ; Lemos, Barbara ; Keedy, Kara ; Fernandes, Prabhavathi</creator><creatorcontrib>Hawser, Stephen ; Morrissey, Ian ; Lemos, Barbara ; Keedy, Kara ; Fernandes, Prabhavathi</creatorcontrib><description>Highlights • The activity of the antibiotic solithromycin was investigated against bacteria from respiratory tract infections (RTI). • Solithromycin exhibited excellent activity against major causative RTI pathogens. • Further monitoring of the activity of solithromycin against RTI pathogens is merited.</description><identifier>ISSN: 0924-8579</identifier><identifier>EISSN: 1872-7913</identifier><identifier>DOI: 10.1016/j.ijantimicag.2017.01.035</identifier><identifier>PMID: 28483717</identifier><language>eng</language><publisher>Netherlands: Elsevier B.V</publisher><subject>Anti-Bacterial Agents - pharmacology ; Antibiotic susceptibility ; Bacteria - drug effects ; Bacteria - isolation &amp; purification ; Bacterial Infections - microbiology ; Community-acquired respiratory tract infection ; Fourth-generation macrolide ; Global Health ; Humans ; Infectious Disease ; Macrolides - pharmacology ; Microbial Sensitivity Tests ; Respiratory Tract Infections - microbiology ; Solithromycin ; Triazoles - pharmacology</subject><ispartof>International journal of antimicrobial agents, 2017-07, Vol.50 (1), p.17-22</ispartof><rights>Elsevier B.V. and International Society of Chemotherapy</rights><rights>2017 Elsevier B.V. and International Society of Chemotherapy</rights><rights>Copyright © 2017 Elsevier B.V. and International Society of Chemotherapy. All rights reserved.</rights><lds50>peer_reviewed</lds50><woscitedreferencessubscribed>false</woscitedreferencessubscribed><citedby>FETCH-LOGICAL-c498t-4dee2c6a0b98fbc07943b6613d1e88906231bb607521a8dd06c80dc0b312967e3</citedby><cites>FETCH-LOGICAL-c498t-4dee2c6a0b98fbc07943b6613d1e88906231bb607521a8dd06c80dc0b312967e3</cites></display><links><openurl>$$Topenurl_article</openurl><openurlfulltext>$$Topenurlfull_article</openurlfulltext><thumbnail>$$Tsyndetics_thumb_exl</thumbnail><link.rule.ids>314,776,780,27901,27902</link.rule.ids><backlink>$$Uhttps://www.ncbi.nlm.nih.gov/pubmed/28483717$$D View this record in MEDLINE/PubMed$$Hfree_for_read</backlink></links><search><creatorcontrib>Hawser, Stephen</creatorcontrib><creatorcontrib>Morrissey, Ian</creatorcontrib><creatorcontrib>Lemos, Barbara</creatorcontrib><creatorcontrib>Keedy, Kara</creatorcontrib><creatorcontrib>Fernandes, Prabhavathi</creatorcontrib><title>Surveillance of the activity of solithromycin (CEM-101) against bacteria from respiratory tract infections</title><title>International journal of antimicrobial agents</title><addtitle>Int J Antimicrob Agents</addtitle><description>Highlights • The activity of the antibiotic solithromycin was investigated against bacteria from respiratory tract infections (RTI). • Solithromycin exhibited excellent activity against major causative RTI pathogens. • Further monitoring of the activity of solithromycin against RTI pathogens is merited.</description><subject>Anti-Bacterial Agents - pharmacology</subject><subject>Antibiotic susceptibility</subject><subject>Bacteria - drug effects</subject><subject>Bacteria - isolation &amp; purification</subject><subject>Bacterial Infections - microbiology</subject><subject>Community-acquired respiratory tract infection</subject><subject>Fourth-generation macrolide</subject><subject>Global Health</subject><subject>Humans</subject><subject>Infectious Disease</subject><subject>Macrolides - pharmacology</subject><subject>Microbial Sensitivity Tests</subject><subject>Respiratory Tract Infections - microbiology</subject><subject>Solithromycin</subject><subject>Triazoles - pharmacology</subject><issn>0924-8579</issn><issn>1872-7913</issn><fulltext>true</fulltext><rsrctype>article</rsrctype><creationdate>2017</creationdate><recordtype>article</recordtype><recordid>eNqNkU1v1DAQhi0EotuFv4DMrT0k-COJ7QsSWhWKVMShcLYcZ9I6JPFiOyvl3-NoC0KcOFmWn3ln5jFCbykpKaHNu6F0g5mTm5w1DyUjVJSEloTXz9COSsEKoSh_jnZEsaqQtVAX6DLGgRBa86p-iS6YrCQXVOzQcL-EE7hxNLMF7HucHgEbm9zJpXW7Rz-69Bj8tFo346vDzZciz3CNzYNxc0y4zTAEZ3CfGRwgHl0wyYcVp5CfsJt7yHF-jq_Qi96MEV4_nXv0_ePNt8Ntcff10-fDh7vCVkqmouoAmG0MaZXsW0uEqnjbNJR3FKRUpGGctm1DRM2okV1HGitJZ0nLKVONAL5HV-fcY_A_F4hJTy5a2FYEv0RNpWpkDs2O9kidURt8jAF6fQxuMmHVlOhNtR70X6r1ploTqrPqXPvmqc3STtD9qfztNgOHMwB52ZODoKN1kDV3LmQluvPuv9q8_yfFjm7O2PgDVoiDX8KcbWqqI9NE329_vn15HoDQitX8F-l_qw0</recordid><startdate>20170701</startdate><enddate>20170701</enddate><creator>Hawser, Stephen</creator><creator>Morrissey, Ian</creator><creator>Lemos, Barbara</creator><creator>Keedy, Kara</creator><creator>Fernandes, Prabhavathi</creator><general>Elsevier B.V</general><scope>CGR</scope><scope>CUY</scope><scope>CVF</scope><scope>ECM</scope><scope>EIF</scope><scope>NPM</scope><scope>AAYXX</scope><scope>CITATION</scope><scope>7X8</scope></search><sort><creationdate>20170701</creationdate><title>Surveillance of the activity of solithromycin (CEM-101) against bacteria from respiratory tract infections</title><author>Hawser, Stephen ; Morrissey, Ian ; Lemos, Barbara ; Keedy, Kara ; Fernandes, Prabhavathi</author></sort><facets><frbrtype>5</frbrtype><frbrgroupid>cdi_FETCH-LOGICAL-c498t-4dee2c6a0b98fbc07943b6613d1e88906231bb607521a8dd06c80dc0b312967e3</frbrgroupid><rsrctype>articles</rsrctype><prefilter>articles</prefilter><language>eng</language><creationdate>2017</creationdate><topic>Anti-Bacterial Agents - pharmacology</topic><topic>Antibiotic susceptibility</topic><topic>Bacteria - drug effects</topic><topic>Bacteria - isolation &amp; purification</topic><topic>Bacterial Infections - microbiology</topic><topic>Community-acquired respiratory tract infection</topic><topic>Fourth-generation macrolide</topic><topic>Global Health</topic><topic>Humans</topic><topic>Infectious Disease</topic><topic>Macrolides - pharmacology</topic><topic>Microbial Sensitivity Tests</topic><topic>Respiratory Tract Infections - microbiology</topic><topic>Solithromycin</topic><topic>Triazoles - pharmacology</topic><toplevel>peer_reviewed</toplevel><toplevel>online_resources</toplevel><creatorcontrib>Hawser, Stephen</creatorcontrib><creatorcontrib>Morrissey, Ian</creatorcontrib><creatorcontrib>Lemos, Barbara</creatorcontrib><creatorcontrib>Keedy, Kara</creatorcontrib><creatorcontrib>Fernandes, Prabhavathi</creatorcontrib><collection>Medline</collection><collection>MEDLINE</collection><collection>MEDLINE (Ovid)</collection><collection>MEDLINE</collection><collection>MEDLINE</collection><collection>PubMed</collection><collection>CrossRef</collection><collection>MEDLINE - Academic</collection><jtitle>International journal of antimicrobial agents</jtitle></facets><delivery><delcategory>Remote Search Resource</delcategory><fulltext>fulltext</fulltext></delivery><addata><au>Hawser, Stephen</au><au>Morrissey, Ian</au><au>Lemos, Barbara</au><au>Keedy, Kara</au><au>Fernandes, Prabhavathi</au><format>journal</format><genre>article</genre><ristype>JOUR</ristype><atitle>Surveillance of the activity of solithromycin (CEM-101) against bacteria from respiratory tract infections</atitle><jtitle>International journal of antimicrobial agents</jtitle><addtitle>Int J Antimicrob Agents</addtitle><date>2017-07-01</date><risdate>2017</risdate><volume>50</volume><issue>1</issue><spage>17</spage><epage>22</epage><pages>17-22</pages><issn>0924-8579</issn><eissn>1872-7913</eissn><abstract>Highlights • The activity of the antibiotic solithromycin was investigated against bacteria from respiratory tract infections (RTI). • Solithromycin exhibited excellent activity against major causative RTI pathogens. • Further monitoring of the activity of solithromycin against RTI pathogens is merited.</abstract><cop>Netherlands</cop><pub>Elsevier B.V</pub><pmid>28483717</pmid><doi>10.1016/j.ijantimicag.2017.01.035</doi><tpages>6</tpages></addata></record>
fulltext fulltext
identifier ISSN: 0924-8579
ispartof International journal of antimicrobial agents, 2017-07, Vol.50 (1), p.17-22
issn 0924-8579
1872-7913
language eng
recordid cdi_proquest_miscellaneous_1896894391
source ScienceDirect Freedom Collection
subjects Anti-Bacterial Agents - pharmacology
Antibiotic susceptibility
Bacteria - drug effects
Bacteria - isolation & purification
Bacterial Infections - microbiology
Community-acquired respiratory tract infection
Fourth-generation macrolide
Global Health
Humans
Infectious Disease
Macrolides - pharmacology
Microbial Sensitivity Tests
Respiratory Tract Infections - microbiology
Solithromycin
Triazoles - pharmacology
title Surveillance of the activity of solithromycin (CEM-101) against bacteria from respiratory tract infections
url http://sfxeu10.hosted.exlibrisgroup.com/loughborough?ctx_ver=Z39.88-2004&ctx_enc=info:ofi/enc:UTF-8&ctx_tim=2025-02-03T11%3A00%3A57IST&url_ver=Z39.88-2004&url_ctx_fmt=infofi/fmt:kev:mtx:ctx&rfr_id=info:sid/primo.exlibrisgroup.com:primo3-Article-proquest_cross&rft_val_fmt=info:ofi/fmt:kev:mtx:journal&rft.genre=article&rft.atitle=Surveillance%20of%20the%20activity%20of%20solithromycin%20(CEM-101)%20against%20bacteria%20from%20respiratory%20tract%20infections&rft.jtitle=International%20journal%20of%20antimicrobial%20agents&rft.au=Hawser,%20Stephen&rft.date=2017-07-01&rft.volume=50&rft.issue=1&rft.spage=17&rft.epage=22&rft.pages=17-22&rft.issn=0924-8579&rft.eissn=1872-7913&rft_id=info:doi/10.1016/j.ijantimicag.2017.01.035&rft_dat=%3Cproquest_cross%3E1896894391%3C/proquest_cross%3E%3Cgrp_id%3Ecdi_FETCH-LOGICAL-c498t-4dee2c6a0b98fbc07943b6613d1e88906231bb607521a8dd06c80dc0b312967e3%3C/grp_id%3E%3Coa%3E%3C/oa%3E%3Curl%3E%3C/url%3E&rft_id=info:oai/&rft_pqid=1896894391&rft_id=info:pmid/28483717&rfr_iscdi=true